Know Cancer

or
forgot password
  • cancer clinical trials in beverly hills, CA

  • A Comparison of DOX-SL Versus Adriamycin Plus Bleomycin Plus Vincristine in the Treatment of Severe AIDS-Related Kaposi's Sarcoma
    Pacific Oaks Med Group
    Beverly Hills, California 90211
    Sarcoma, Kaposi, HIV Infections
    Gefitinib, Trastuzumab, and Docetaxel in Treating Patients With Metastatic Breast Cancer
    Tower Cancer Research Foundation
    Beverly Hills, California 90211
    Breast Cancer
    Eribulin Mesylate in Treating Patients With Locally Advanced or Metastatic Cancer of the Urothelium and Kidney Dysfunction
    Tower Cancer Research Foundation
    Beverly Hills, California 90211
    Distal Urethral Cancer, Metastatic Transitional Cell Cancer of the Renal Pelvis and Ureter, Proximal Urethral Cancer, Recurrent Bladder Cancer, Recurrent Transitional Cell Cancer of the Renal Pelvis and Ureter, Recurrent Urethral Cancer, Regional Transitional Cell Cancer of the Renal Pelvis and Ureter, Stage III Bladder Cancer, Stage IV Bladder Cancer, Transitional Cell Cancer of the Renal Pelvis and Ureter, Urethral Cancer, Urethral Cancer Associated With Invasive Bladder Cancer
    Assessment Tool for Older Patients With Cancer
    Tower Cancer Research Foundation
    Beverly Hills, California 90211
    Cognitive/Functional Effects, Psychosocial Effects of Cancer and Its Treatment, Unspecified Adult Solid Tumor, Protocol Specific
    Phase 2 Study of Carfilzomib in Relapsed and Refractory Multiple Myeloma
    Tower Cancer Research Foundation
    Beverly Hills, California 90211
    Multiple Myeloma
    LUX Lung 2 Phase II Single Arm BIBW 2992 "Afatinib" in NSCLC With EGFR Activating Mutations
    1200.22.32 Boehringer Ingelheim Investigational Site
    Beverly Hills, California
    Carcinoma, Non-Small-Cell Lung
    Phase 2 Study of Carfilzomib in Relapsed Multiple Myeloma
    Tower Cancer Research Foundation
    Beverly Hills, California 90211
    Multiple Myeloma
    Phase 1b/2 Study of Carfilzomib in Relapsed Solid Tumors, Multiple Myeloma, or Lymphoma
    Tower Cancer Research Foundation
    Beverly Hills, California 90211
    Ovarian Cancer, Renal Cancer, Non-small Cell Lung Cancer, Small Cell Lung Cancer, Solid Tumors, Multiple Myeloma, Lymphoma
    Safety Study of TAK-700 in Subjects With Prostate Cancer.
    USC Westside Prostate Cancer Center
    Beverly Hills, California
    Prostatic Neoplasms
    Safety Study & Effectiveness of Docetaxel With RAD001 and Bevacizumab in Men With Advanced Prostate Cancer
    Westside Prostate Cancer Center, University of Southern California
    Beverly Hills, California 90211
    Prostate Cancer
    Vorinostat and Rituximab in Treating Patients With Indolent Non-Hodgkin Lymphoma
    Tower Cancer Research Foundation
    Beverly Hills, California 90211
    Lymphoma
    Bendamustine Combined With Rituximab for Patients With Relapsed or Refractory Diffuse Large B-Cell Lymphoma
    Pharmatech Oncology Study Site
    Beverly Hills, California 90211
    Diffuse Large B-Cell Lymphoma
    Phase III Study of ABI-007(Albumin-bound Paclitaxel) Plus Gemcitabine Versus Gemcitabine in Metastatic Adenocarcinoma of the Pancreas
    Tower Cancer Research Foundation
    Beverly Hills, California 90211
    Metastatic Pancreatic Cancer
    Dasatinib in Treating Patients With Recurrent or Metastatic Malignant Salivary Gland Tumors
    Tower Cancer Research Foundation
    Beverly Hills, California 90211
    High-grade Salivary Gland Mucoepidermoid Carcinoma, Low-grade Salivary Gland Mucoepidermoid Carcinoma, Recurrent Salivary Gland Cancer, Salivary Gland Acinic Cell Tumor, Salivary Gland Adenocarcinoma, Salivary Gland Adenoid Cystic Carcinoma, Salivary Gland Anaplastic Carcinoma, Salivary Gland Malignant Mixed Cell Type Tumor, Salivary Gland Poorly Differentiated Carcinoma, Salivary Gland Squamous Cell Carcinoma, Stage IV Salivary Gland Cancer
    A Trial of ABI-007 Versus Dacarbazine in Previously Untreated Patients With Metastatic Malignant Melanoma
    Tower Cancer Research Foundation
    Beverly Hills, California 90211
    Malignant Melanoma
    A Phase 2 Multi-Center Study of Entinostat (SNDX-275) in Patient With Relapsed or Refractory Hodgkin's Lymphoma
    Tower Cancer Research Foundaton
    Beverly Hills, California
    Hodgkin's Lymphoma
    A Study of Carfilzomib Maintenance Therapy in Subjects Previously Enrolled in Carfilzomib Treatment Protocols
    Tower Cancer Research Foundation
    Beverly Hills, California 90211
    Multiple Myeloma
    A Study of MLN9708 in Adult Patients With Lymphoma
    Tower Cancer Research Center
    Beverly Hills, California 90211
    Lymphoma
    Study to Assess the Effectiveness of RCHOP With or Without VELCADE in Previously Untreated Non-Germinal Center B-Cell-like Diffuse Large B-Cell Lymphoma Patients
    Tower Cancer Research Foundation
    Beverly Hills, California 90211
    Non-Germinal B-Cell-like (GCB) Diffuse Large B-cell Lymphoma (DLBCL)
    Myelodysplastic Syndromes (MDS) Event Free Survival With Iron Chelation Therapy Study
    Tower Cancer Research Tower Oncology
    Beverly Hills, California 90211
    Myelodysplastic Syndromes
    Alvocidib and Oxaliplatin With or Without Fluorouracil and Leucovorin Calcium in Treating Patients With Relapsed or Refractory Germ Cell Tumors
    Tower Cancer Research Foundation
    Beverly Hills, California 90211
    Recurrent Extragonadal Germ Cell Tumor, Recurrent Extragonadal Non-seminomatous Germ Cell Tumor, Recurrent Extragonadal Seminoma, Recurrent Malignant Testicular Germ Cell Tumor, Recurrent Ovarian Germ Cell Tumor, Stage III Malignant Testicular Germ Cell Tumor, Stage IV Extragonadal Non-seminomatous Germ Cell Tumor, Stage IV Extragonadal Seminoma, Stage IV Ovarian Germ Cell Tumor
    Study of Pralatrexate to Treat Patients With Relapsed or Refractory B-cell Non-Hodgkin's Lymphoma
    Tower Cancer Research Foundation
    Beverly Hills, California 90211
    Lymphoma, B-Cell
    Temsirolimus and Bevacizumab in Treating Patients With Advanced Endometrial, Ovarian, Liver, Carcinoid, or Islet Cell Cancer
    Tower Cancer Research Foundation
    Beverly Hills, California 90211
    Adult Primary Hepatocellular Carcinoma, Advanced Adult Primary Liver Cancer, Endometrial Papillary Serous Carcinoma, Localized Unresectable Adult Primary Liver Cancer, Metastatic Gastrointestinal Carcinoid Tumor, Ovarian Carcinosarcoma, Ovarian Endometrioid Adenocarcinoma, Ovarian Mixed Epithelial Carcinoma, Ovarian Papillary Serous Carcinoma, Pancreatic Alpha Cell Adenoma, Pancreatic Alpha Cell Carcinoma, Pancreatic Beta Islet Cell Adenoma, Pancreatic Beta Islet Cell Carcinoma, Pancreatic Delta Cell Adenoma, Pancreatic Delta Cell Carcinoma, Pancreatic G-cell Adenoma, Pancreatic G-cell Carcinoma, Pancreatic Polypeptide Tumor, Pulmonary Carcinoid Tumor, Recurrent Adult Primary Liver Cancer, Recurrent Endometrial Carcinoma, Recurrent Fallopian Tube Cancer, Recurrent Gastrointestinal Carcinoid Tumor, Recurrent Islet Cell Carcinoma, Recurrent Ovarian Epithelial Cancer, Recurrent Primary Peritoneal Cavity Cancer, Regional Gastrointestinal Carcinoid Tumor, Stage IIIA Endometrial Carcinoma, Stage IIIA Fallopian Tube Cancer, Stage IIIA Ovarian Epithelial Cancer, Stage IIIA Primary Peritoneal Cavity Cancer, Stage IIIB Endometrial Carcinoma, Stage IIIB Fallopian Tube Cancer, Stage IIIB Ovarian Epithelial Cancer, Stage IIIB Primary Peritoneal Cavity Cancer, Stage IIIC Endometrial Carcinoma, Stage IIIC Fallopian Tube Cancer, Stage IIIC Ovarian Epithelial Cancer, Stage IIIC Primary Peritoneal Cavity Cancer, Stage IV Fallopian Tube Cancer, Stage IV Ovarian Epithelial Cancer, Stage IV Primary Peritoneal Cavity Cancer, Stage IVA Endometrial Carcinoma, Stage IVB Endometrial Carcinoma, Uterine Carcinosarcoma
    Gemcitabine Hydrochloride With or Without Vismodegib in Treating Patients With Recurrent or Metastatic Pancreatic Cancer
    Tower Cancer Research Foundation
    Beverly Hills, California 90211
    Adenocarcinoma of the Pancreas, Recurrent Pancreatic Cancer, Stage IV Pancreatic Cancer
    RO4929097 Before Surgery in Treating Patients With Pancreatic Cancer
    Tower Cancer Research Foundation
    Beverly Hills, California 90211
    Adenocarcinoma of the Pancreas, Stage IA Pancreatic Cancer, Stage IB Pancreatic Cancer, Stage IIA Pancreatic Cancer, Stage IIB Pancreatic Cancer
    MEK Inhibitor AZD6244 With or Without Temsirolimus in Treating Patients With Metastatic, Recurrent, or Locally Advanced Soft Tissue Sarcoma That Cannot Be Removed By Surgery
    Tower Cancer Research Foundation
    Beverly Hills, California 90211
    Recurrent Adult Soft Tissue Sarcoma, Stage III Adult Soft Tissue Sarcoma, Stage IV Adult Soft Tissue Sarcoma
    A Safety and Efficacy Study of Farletuzumab in Subjects With Adenocarcinoma of the Lung
    Providence Health System
    Beverly Hills, California 90210-5501
    Adenocarcinoma of the Lung
    MK2206 in Treating Patients With Advanced Liver Cancer That Did Not Respond to Previous Therapy
    Tower Cancer Research Foundation
    Beverly Hills, California 90211
    Adult Primary Hepatocellular Carcinoma, Advanced Adult Primary Liver Cancer, Localized Unresectable Adult Primary Liver Cancer, Recurrent Adult Primary Liver Cancer
    Aldesleukin With or Without Aflibercept in Treating Patients With Stage III or Stage IV Melanoma That Cannot Be Removed By Surgery
    Tower Cancer Research Foundation
    Beverly Hills, California 90211
    Recurrent Melanoma, Stage IIIA Melanoma, Stage IIIB Melanoma, Stage IIIC Melanoma, Stage IV Melanoma
    Capecitabine and Vorinostat in Treating Patients With Recurrent and/or Metastatic Head and Neck Cancer
    Tower Cancer Research Foundation
    Beverly Hills, California 90211
    Metastatic Squamous Neck Cancer With Occult Primary Squamous Cell Carcinoma, Recurrent Metastatic Squamous Neck Cancer With Occult Primary, Recurrent Squamous Cell Carcinoma of the Hypopharynx, Recurrent Squamous Cell Carcinoma of the Larynx, Recurrent Squamous Cell Carcinoma of the Lip and Oral Cavity, Recurrent Squamous Cell Carcinoma of the Nasopharynx, Recurrent Squamous Cell Carcinoma of the Oropharynx, Recurrent Squamous Cell Carcinoma of the Paranasal Sinus and Nasal Cavity, Recurrent Verrucous Carcinoma of the Larynx, Recurrent Verrucous Carcinoma of the Oral Cavity, Stage III Squamous Cell Carcinoma of the Lip and Oral Cavity, Stage IV Squamous Cell Carcinoma of the Hypopharynx, Stage IV Squamous Cell Carcinoma of the Larynx, Stage IV Squamous Cell Carcinoma of the Lip and Oral Cavity, Stage IV Squamous Cell Carcinoma of the Nasopharynx, Stage IV Squamous Cell Carcinoma of the Oropharynx, Stage IV Squamous Cell Carcinoma of the Paranasal Sinus and Nasal Cavity, Stage IV Verrucous Carcinoma of the Larynx, Stage IV Verrucous Carcinoma of the Oral Cavity, Tongue Cancer
    MK2206 and Erlotinib Hydrochloride in Treating Patients With Advanced Non-Small Cell Lung Cancer Who Have Progressed After Previous Response to Erlotinib Hydrochloride Therapy
    Tower Cancer Research Foundation
    Beverly Hills, California 90211
    Adenocarcinoma of the Lung, Adenosquamous Cell Lung Cancer, Bronchoalveolar Cell Lung Cancer, Large Cell Lung Cancer, Recurrent Non-small Cell Lung Cancer, Squamous Cell Lung Cancer
    Veliparib With or Without Radiation Therapy, Carboplatin, and Paclitaxel in Patients With Stage III Non-Small Cell Lung Cancer That Cannot Be Removed by Surgery
    Tower Cancer Research Foundation
    Beverly Hills, California 90211
    Adenocarcinoma of the Lung, Adenosquamous Cell Lung Cancer, Bronchoalveolar Cell Lung Cancer, Large Cell Lung Cancer, Squamous Cell Lung Cancer, Stage IIIA Non-small Cell Lung Cancer, Stage IIIB Non-small Cell Lung Cancer
    MLN8237 in Patients With Relapsed or Refractory Aggressive B-Cell Lymphoma Treated With Rituximab & Vincristine
    Providence Health Services
    Beverly Hills, California 90211
    Diffuse Large B-Cell Lymphoma, Transformed Follicular Lymphoma, Mantle Cell Lymphoma, Burkitt's Lymphoma
    Study of MK-3475 Versus Chemotherapy in Participants With Advanced Melanoma (P08719/MK-3475-002 AM1)
    Call for Information (Investigational Site 0061)
    Beverly Hills, California 90211
    Malignant Melanoma
    Validating a New Severity Score System for Adults With Type 1 Gaucher Disease (GD1)
    Tower Cancer Research Foundation
    Beverly Hills, California 90211
    Gaucher Disease
    A Study of DOX-SL in the Treatment of AIDS-Related Kaposi's Sarcoma
    Pacific Oaks Med Group
    Beverly Hills, California 90211
    Sarcoma, Kaposi, HIV Infections
    Nolatrexed Dihydrochloride Compared With Doxorubicin in Treating Patients With Recurrent or Unresectable Liver Cancer
    Tower Cancer Research Foundation
    Beverly Hills, California 90211
    Liver Cancer
    HORIZON-PFT: Pivotal Fracture Trial
    Osteoporosis Medical Center
    Beverly Hills, California 90211
    Osteoporosis
    Ziconotide Effectiveness and Safety Trial in Patients With Chronic Severe Pain
    Shreenath Clinical Services
    Beverly Hills, California 90211
    Pain
    Alternative Dosing Regimens of Subcutaneous Azacitidine for Myelodysplastic Syndromes
    Tower Cancer Research Foundation
    Beverly Hills, California 90211
    Myelodysplastic Syndromes
    Vaccine Therapy and GM-CSF in Treating Patients With Progressive Non-Hodgkin's Lymphoma
    Tower Cancer Research Foundation
    Beverly Hills, California 90211
    Lymphoma
    Safety and Efficacy of Treandaâ„¢ (Bendamustine HCl) in Patients With Indolent Non-Hodgkin's Lymphoma (NHL) Who Are Refractory to Rituximab
    Tower Hematology and Oncology Medical Group
    Beverly Hills, California 90211
    Non-Hodgkin's Lymphoma
    Safety Study of the Proteasome Inhibitor PR-171 (Carfilzomib for Injection) in Patients With Hematological Malignancies
    Tower Cancer Research Foundation
    Beverly Hills, California 90211
    Waldenstrom's Macroglobulinemia
    Gemcitabine/Irinotecan/ZD1839 vs Paclitaxel/Carboplatin/Etoposide/ZD1839 in Carcinoma of Unknown Primary Site
    Tower Oncology
    Beverly Hills, California 90211
    Neoplasms, Unknown Primary
    A Study of ONTAK in Patients With Relapsed or Refractory, B-Cell Non Hodgkin's Lymphoma
    Tower Cancer Research Foundation
    Beverly Hills, California 90211
    Lymphoma, B-Cell
    A Survival Study for Women With Advanced Lung Cancer Who Have Not Previously Received Chemotherapy.
    Tower Cancer Research Foundation
    Beverly Hills, California 90211
    NSCLC
    Open-Label Study to Evaluate the Effect of Treatment With Fentanyl Buccal Tablets on Pain Anxiety Symptoms When Used for the Management of Breakthrough Pain
    Lovelace Scientific Resources, Inc.
    Beverly Hills, California 90211
    Pain, Chronic Pain, Breakthrough Pain
    Apixaban for the Prevention of Stroke in Subjects With Atrial Fibrillation
    Act/Cardiovascular Research Institute
    Beverly Hills, California 90210
    Atrial Fibrillation, Atrial Flutter
    A Study to Evaluate Lenalidomide Combined With Dexamethasone in Relapsed or Refractory Diffuse Large B-Cell Lymphoma
    Tower Cancer Research Foundation
    Beverly Hills, California 90211
    Diffuse Large B-cell Lymphoma
    Study Evaluating Effects of CX-3543 in Patients With Relapsed or Refractory B-Cell Chronic Lymphocytic Leukemia
    Tower Cancer Research Foundation
    Beverly Hills, California 90211
    B-Cell Chronic Lymphocytic Leukemia
    Safety Study of PRLX 93936 in Patients With Advanced Solid Tumors
    Tower Cancer Research Foundation
    Beverly Hills, California 90211
    Cancer
    A Study of Lintuzumab (SGN-33) in Combination With Low Dose Cytarabine in Patients 60+ Years With AML
    Tower Cancer Research Foundation
    Beverly Hills, California 90211
    Acute Myeloid Leukemia
    Molecular Profiling Protocol (SCRI-CA-001)
    Tower Oncology
    Beverly Hills, California 90211
    Refractory Cancer
    PR104 in Treating Patients With Previously Untreated or Relapsed Small Cell Lung Cancer
    Tower Cancer Research Foundation
    Beverly Hills, California 90211
    Lung Cancer